InsideArbitrage Event Driven Monitor – January 2, 2023

Quick updates on the event-driven strategies we follow on InsideArbitrage.

Merger Arbitrage

1. Apollo Endosurgery (APEN) and Boston Scientific (BSX) stated in their preliminary proxy statement that they filed notification and report forms under the HSR Act with the DOJ and the FTC on December 20, 2022.
2. F-star Therapeutics (FSTX) and invoX Pharma extended the tender offer to January 17, 2023, to give CFIUS more time. The End Date has also been extended to January 31, 2023.
3. Canada’s antitrust regulator plans to appeal a decision by a Canadian court that allowed a proposed merger between Rogers Communications (RCI) and Shaw Communications (SJR) to proceed. The Competition Bureau has filed a notice to appeal the decision with a Canadian appellate court. The companies reported that they remain committed to pro-competitive transactions.

Only plus or premium subscribers can access this post. Subscribe today.